Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

The role of SLC2A1 mutations in myoclonic astatic epilepsy and absence epilepsy, and the estimated frequency of GLUT1 deficiency syndrome.

Authors: Larsen, J  Johannesen, KM  Ek, J  Tang, S  Marini, C  Blichfeldt, S  Kibaek, M  Von Spiczak, S  Weckhuysen, S  Frangu, M  Neubauer, BA  Uldall, P  Striano, P  Zara, F  Kleiss, R  Simpson, M  Muhle, H  Nikanorova, M  Jepsen, B  Tommerup, N  Stephani, U  Guerrini, R  Duno, M  Hjalgrim, H  Pal, D  Helbig, I  Moller, RS  Møller, Rikke Steensbjerre 
Citation: Larsen J, etal., Epilepsia. 2015 Dec;56(12):e203-8. doi: 10.1111/epi.13222. Epub 2015 Nov 5.
Pubmed: (View Article at PubMed) PMID:26537434
DOI: Full-text: DOI:10.1111/epi.13222

The first mutations identified in SLC2A1, encoding the glucose transporter type 1 (GLUT1) protein of the blood-brain barrier, were associated with severe epileptic encephalopathy. Recently, dominant SLC2A1 mutations were found in rare autosomal dominant families with various forms of epilepsy including early onset absence epilepsy (EOAE), myoclonic astatic epilepsy (MAE), and genetic generalized epilepsy (GGE). Our study aimed to investigate the possible role of SLC2A1 in various forms of epilepsy including MAE and absence epilepsy with early onset. We also aimed to estimate the frequency of GLUT1 deficiency syndrome in the Danish population. One hundred twenty patients with MAE, 50 patients with absence epilepsy, and 37 patients with unselected epilepsies, intellectual disability (ID), and/or various movement disorders were screened for mutations in SLC2A1. Mutations in SLC2A1 were detected in 5 (10%) of 50 patients with absence epilepsy, and in one (2.7%) of 37 patient with unselected epilepsies, ID, and/or various movement disorders. None of the 120 MAE patients harbored SLC2A1 mutations. We estimated the frequency of SLC2A1 mutations in the Danish population to be approximately 1:83,000. Our study confirmed the role of SLC2A1 mutations in absence epilepsy with early onset. However, our study failed to support the notion that SLC2A1 aberrations are a cause of MAE without associated features such as movement disorders.


Disease Annotations
Objects Annotated

Additional Information

CRRD Object Information
CRRD ID: 11058811
Created: 2016-04-13
Species: All species
Last Modified: 2016-04-13
Status: ACTIVE


RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.